ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Conte Institute Leafs Scientific Effort On Central Europe Environmental Clean-Up

March 19, 1993

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

The Cancer Letter Marks 25th Anniversary

December 18, 1998